85% of African American adults expressed interest in genetic testing for AD susceptibility

NewsGuard 100/100 Score

Alcohol dependence (AD) has a genetic component and testing can determine a person's genetic risk for susceptibility to AD. A new study shows that while more than 85% of the African American adults expressed an interest in genetic testing for AD susceptibility, many had ethical, privacy, and procedural concerns, as reported in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Genetic Testing and Molecular Biomarkers website.

Denise Scott and coauthors from Howard University (Washington, DC) and Johns Hopkins University Bloomberg School of Public Health (Baltimore, MD) offered hypothetical genetic testing for AD susceptibility to more than 300 African American adults to determine their interest level. The researchers documented the factors that contributed to an interest in being tested and those that might keep people from undergoing genetic risk assessment due to concerns over the testing methods and how the results would be used in the article "Genetic Testing for the Susceptibility to Alcohol Dependence: Interest and Concerns in an African American Population." 

"The article documents the interest the African American community has about a possible genetic basis for alcoholism tempered by a real concern about privacy," says Kenneth I. Berns, MD, PhD, Editor-in-Chief of Genetic Testing and Molecular Biomarkers, and Director of the University of Florida's Genetics Institute, College of Medicine, Gainesville, FL.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Siblings with unique gene mutation offer insights into type 1 diabetes treatment